Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Atrasentan MeSH Descriptor Data 2026


MeSH Heading
Atrasentan
Tree Number(s)
D03.383.246.118.300
D03.383.773.079
D03.633.100.115.300
Unique ID
D000077868
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077868
Scope Note
A pyrrolidine and benzodioxole derivative that acts a RECEPTOR, ENDOTHELIN A antagonist. It has therapeutic potential as an antineoplastic agent and for the treatment of DIABETIC NEPHROPATHIES.
Entry Term(s)
(11C)ABT-627
2-(4-Methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(((dibutylamino)carbonyl)methyl)pyrrolidine-3-carboxylic acid
A 127722
A 147627
A-127722
A-127722.5
A-147627
ABT 627
ABT-627
Atrasentan Hydrochloride
Xinlay
Pharm Action
Antineoplastic Agents
Endothelin A Receptor Antagonists
Registry Numbers
V6D7VK2215
0
E4G31X93ZA
Related Numbers
E4G31X93ZA
CAS Type 1 Name
3-Pyrrolidinecarboxylic acid, 4-(1,3-benzodioxol-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-, (2R,3R,4S)-
Public MeSH Note
2019; ATRASENTAN was indexed under PYRROLIDINES 1996-2018
History Note
2019 (1996)
Date Introduced
2019/01/01
Last Updated
2019/01/01
Atrasentan Preferred
ABT 627 Narrower
A 127722 Narrower
Xinlay Narrower
(11C)ABT-627 Narrower
2-(4-Methoxyphenyl)-4-(1,3-benzodioxol-5-yl)-1-(((dibutylamino)carbonyl)methyl)pyrrolidine-3-carboxylic acid Broader
A 147627 Narrower
Atrasentan Hydrochloride Narrower
page delivered in 0.14s